CAS: 432529-82-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | BCI-121 REF: IN-DA01EO5YCAS: 432529-82-3 | 98% | A consultar | Mar 07 Ene 25 |
 | BCI-121 REF: 54-BISN0081CAS: 432529-82-3 | 99% | 152,00 €~1.237,00 € | Mar 14 Ene 25 |
 | BCI-121 REF: TM-T5322CAS: 432529-82-3 | 99.67% | 35,00 €~467,00 € | Mar 14 Ene 25 |
 | BCI-121 REF: 3D-HSA52982CAS: 432529-82-3 | Min. 95% | A consultar | Mar 18 Feb 25 |
Ref: IN-DA01EO5Y
| 1g | A consultar | ||
| 100mg | 194,00 € | ||
| 250mg | 499,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Ref: 54-BISN0081
| 1g | 1.237,00 € | ||
| 100mg | 272,00 € | ||
| 250mg | 477,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
BCI-121
CAS:432529-82-3
BCI-121 is a substrate-competitive SMYD3 inhibitor that inhibits the proliferation of the cancer cell.
Fórmula:
C14H18BrN3O2
Pureza:
99.67%
Forma y color:
Solid
Peso molecular:
340.22
Ref: TM-T5322
| 1mg | 35,00 € | ||
| 5mg | 65,00 € | ||
| 10mg | 96,00 € | ||
| 25mg | 185,00 € | ||
| 50mg | 294,00 € | ||
| 100mg | 467,00 € | ||
| 1mL*10mM (DMSO) | 72,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
BCI-121
CAS:432529-82-3
BCI-121 is an investigational drug that inhibits the enzyme lysine methyltransferase (KMT), which is involved …
Fórmula:
C14H18BrN3O2
Pureza:
Min. 95%
Peso molecular:
340.22 g/mol
Ref: 3D-HSA52982
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
